SkQ1: Research, Dosing, and Where to Buy in 2026
A research-first profile for SkQ1 (SQ1), aggregating mechanism notes, transcript dosing mentions, vendor recommendations, and PubMed-indexed literature without presenting medical guidance.
SkQ1 is a research compound profiled here from named-expert transcripts and peer-reviewed literature, without medical guidance. As of July 2026, The Peptide Wiki aggregates 8 PubMed-cited papers for SkQ1, each linked to its source.
- Also indexed as SQ1.
- 0 aggregated dosing-protocol mentions from source transcripts.
- 8 PubMed-indexed citations listed in the research table below.
- 0 vendor recommendations captured from named experts.
What is SkQ1?
Research compound aggregated from creator and literature mentions. No direct disease-treatment claims are made on this page.
SkQ1 Dosing Protocols
The entries below are transcript-derived dosing mentions. They are preserved for research context and are not medical advice.
No transcript-derived dosing mentions in current source set.
Where to Buy SkQ1 in 2026
No tracked vendor recommendations for SkQ1 yet. See our vendor directory.
Side Effects and Safety
Anecdotal reports and study-level observations vary by route, dose, and individual. This page does not provide medical advice. Consult a qualified clinician before any research use.
User Reviews
User reviews aggregator coming Q3 2026 (Reddit + YouTube comments + Discord research notes). Until then, see the expert quote section above and PubMed citations below.
Research Efficacy Snapshot
Published efficacy percentages cited in PubMed trials and named-expert reports about SkQ1. Each line links to the original source.
- "Methods and results: A 40% fixed-blood-loss HS rat model was established in this study." · Jia B et al, 2022 PubMed
- "RNA-seq transcriptome analysis showed that 56.5% of the inflammation-related genes, which altered after HS, could be significantly reversed after SkQ1 treatment." · Jia B et al, 2022 PubMed
- "The wound closure rates were increased by 4% in 4 h and by 9% after 8-12 h in the presence of 50 nM SkQ1." · Wei Y et al, 2019 PubMed
Research and Studies
8 PubMed-indexed papers reference SkQ1. Top 8 shown.
Legal Status
SkQ1 is presented here as a research compound. FDA approval status, scheduling, WADA status, and state-specific telehealth rules may apply. Always verify current regulatory status. Last verified: 2026-07-09.
Frequently Asked Questions
Is SkQ1 FDA-approved?
SkQ1 is presented on this page as a research compound. FDA approval status, scheduling, and state-specific rules may apply and change. Verify current regulatory status before any decision.
How much research has been published on SkQ1?
8 PubMed-indexed paper(s) reference SkQ1 in our current research feed. See the Research and Studies section above for citations.